Explore Edesa Biotech, Inc.'s Q4 2024 financial analysis, highlighting comprehensive losses, strategic funding, and cautious investor recommendations. Key insights on market position and future commitments.
Explore Edessa Biotech Inc.'s latest 8-K report filed on February 14, 2025, detailing significant stock and corporate changes. Stay informed on EDSA's developments.
Explore Edesa Biotech, Inc.'s 8-K report, filed on February 12, 2025, detailing crucial updates for shareholders. Focused on corporate governance and compliance.
Discover the latest insights from Edesa Biotech's Amendment No. 1 to their Annual Report 10-K, detailing shareholder disclosures and filing updates for FY 2024.